HOME >> MEDICINE >> NEWS
Studies Look At Threshold Effect Of Cholesterol-Lowering "Statin" Drugs

DALLAS, April 21 -- Do individuals gain progressive benefits in heart attack protection as the drugs, called statins, take cholesterol levels to "new lows?" This is the topic of three reports and an editorial appearing in today's Circulation: Journal of the American Heart Association.

"An important question is how much additional benefit do individuals who have had a heart attack get from reducing their low-density lipoprotein, (LDL), or 'bad' cholesterol levels from low to very low levels, (below the recommended 100 milligrams/deciliter)? Is it considerable, small amounts or none?" asks Scott M. Grundy, M.D., Ph.D., who wrote an accompanying editorial in Circulation. He is director of the center for human nutrition at the University of Texas Southwestern Medical Center in Dallas.

In one report researchers found that the benefits of the popular statin drugs -- shown to sharply reduce heart attack risk in individuals with elevated blood levels of cholesterol -- taper off, indicating a "threshold" effect when LDL reaches 125 mg/dL, according to Frank M. Sacks, M.D., associate professor of medicine, and other researchers at Brigham and Women's Hospital and Harvard Medical School, Boston.

Another report in the same issue however suggested continued benefit down to a level of 100 mg/dL, although there was some lessening of benefit as LDL approached the lower levels.

Even though the data suggest that there may be attenuation in the benefit of cholesterol lowering below 125 mg/dL, Grundy stresses that these reports should not be taken as the final word on the issue. "For the present, the guidelines by the National Cholesterol Education Program (NCEP), endorsed by the American Heart Association, offer the most reliable basis for physicians' decisions regardless of the optimal lower limit for LDL cholesterol," says Grundy. A new statin trial, the Treating to New Target (TNT) study, should provide the answers concerning lower limit of benefit, but
'"/>

Contact: Carole Bullock
caroleb@amhrt.org
214-706-1279
American Heart Association
20-Apr-1998


Page: 1 2 3 4 5

Related medicine news :

1. Studies underscore genetic involvement in nicotine addiction & aggressive hostility
2. Studies address issues of risk and survival in rapidly increasing GI cancers
3. Studies examine coffee drinking and risk of liver and colorectal cancers
4. Studies reveal physicians attitudes on end-of-life care
5. Studies from the November issue of The Archives of Dermatology, a theme issue on facial rejuvenation
6. Studies link obesity to increased frequency of heartburn symptoms; greater risk of esophageal cancer
7. Studies demonstrate positive data in treatment of hepatitis C
8. Studies examine risk factors and potential consequences associated with prehypertension
9. Studies show ACTOS(R) (pioglitazone HCl) has positive effects on various components of dyslipidemia
10. Studies identify risk factors for colon cancer
11. Studies indicate healthy eating may affect cancer development, improve digestive system

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/28/2020)... ... May 28, 2020 , ... ... is joining the clinically integrated network (CIN) and the group purchasing organization run ... Cardiovascular Institute to establish a heart failure program at Mon Health Medical Center. ...
(Date:5/27/2020)... ... May 27, 2020 , ... The podiatrists and foot ... Howell Michigan, Fowlerville Michigan , and Ann Arbor Michigan. Dr. Tomasz Biernacki ... patients within the clinic and at the hospital. We have been seeing patients in ...
(Date:5/26/2020)... ... May 26, 2020 , ... ... availability of two leading RevSpring solutions—Talksoft® patient messaging and IVR Advantage™--for Loyale ... engaging patients through automated and precise texts, IVR reminders and email messages ...
(Date:5/25/2020)... ... , ... Winemaker Grant Long Jr. is introducing three Toilet Paper Reserve wines. ... in these complicated times,” he said, in announcing the new wines. The wines are ... and Red Wine Blend are sourced in the Napa Valley; the Grenache comes from ...
(Date:5/21/2020)... ... May 21, 2020 , ... Fujirebio Diagnostics, ... cancer biomarker assays, announced today that Cigna has added ROMA® (Risk of Ovarian ... health service company dedicated to improving the health, well-being, and peace of mind ...
Breaking Medicine News(10 mins):
(Date:6/4/2020)... SAN MATEO, Calif. (PRWEB) , ... June 04, 2020 , ... ... international travel was restricted, and “social distancing” entered the lexicon. COVID-19 turned the world ... important to stay “sheltered in place.” , The AutismOne annual conference went from a ...
(Date:6/3/2020)... ... ... The Conference Forum announced the launch of the first virtual program for the ... This annual conference challenges biopharma R&D on how to embrace, adapt and scale mobile ... clinical research. , “This event comes at a critical time,” says Mark Scherzer, conference ...
(Date:6/3/2020)... ... June 03, 2020 , ... ... 75, announced today the addition of connected device capabilities to its mobile device ... The expanded capabilities come at a time when an increasing number of home ...
Breaking Medicine Technology:
Cached News: